Murphy USA Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Murphy USA Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $21.53B | Feb 16, 2024 |
| FY2023 | Dec 31, 2022 | $23.45B | Feb 16, 2024 |
| FY2023 | Dec 31, 2021 | $17.36B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $11.26B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $14.03B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $14.36B | Feb 19, 2021 |
| FY2017 | Dec 31, 2017 | $3.38B | Feb 20, 2018 |
| FY2017 | Sep 30, 2017 | $3.24B | Feb 20, 2018 |
| FY2017 | Jun 30, 2017 | $3.21B | Feb 20, 2018 |
| FY2017 | Mar 31, 2017 | $3.00B | Feb 20, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $470.60M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $502.50M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $556.80M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $672.90M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $396.90M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $386.10M | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | $47.60M | Feb 18, 2020 |
| FY2019 | Sep 30, 2019 | $69.20M | Feb 18, 2020 |
| FY2019 | Jun 30, 2019 | $32.70M | Feb 18, 2020 |
| FY2019 | Mar 31, 2019 | $5.30M | Feb 18, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $718.50M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $742.90M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $826.00M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $968.40M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $604.00M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $559.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $268.50M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $325.10M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $283.30M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $388.10M | Feb 19, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $231.50M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $235.40M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $240.50M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $232.50M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $193.60M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $171.10M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $144.60M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $136.20M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $141.20M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $122.70M | Feb 19, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $813.90M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $847.60M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $784.00M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $994.70M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $737.40M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $563.70M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $313.30M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $398.70M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $283.60M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $337.40M | Feb 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.73B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $4.54B | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $4.34B | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $4.12B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $4.05B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $2.69B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $2.69B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $2.36B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $2.33B | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $2.09B | Feb 19, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.10B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $3.70B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $3.51B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $3.48B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $3.24B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $1.90B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $1.88B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.55B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $1.59B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $1.39B | Feb 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $623.50M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $840.10M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $828.90M | Feb 18, 2026 |
| FY2025 | Dec 31, 2022 | $640.70M | Feb 18, 2026 |
| FY2024 | Dec 31, 2021 | $807.20M | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | $784.10M | Feb 16, 2024 |
| FY2022 | Dec 31, 2019 | $803.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2018 | $807.30M | Feb 17, 2022 |
| FY2020 | Dec 31, 2017 | $738.40M | Feb 19, 2021 |
| FY2019 | Dec 31, 2016 | $697.00M | Feb 18, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $328.00M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $328.00M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $328.00M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $328.00M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $328.00M | Feb 15, 2023 |
| FY2022 | Dec 31, 2020 | $0 | Feb 15, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.17B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $3.74B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $3.28B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $2.76B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $2.11B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $1.74B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $1.36B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.21B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $994.50M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $749.27M | Feb 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.90M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $47.00M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $117.80M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $60.50M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $256.40M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $163.60M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $280.30M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $184.50M | Feb 18, 2020 |
| FY2019 | Dec 31, 2017 | $170.00M | Feb 18, 2020 |
| FY2019 | Dec 31, 2016 | $153.80M | Feb 18, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $492.44M | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | $561.58M | Feb 27, 2015 |
| FY2013 | Dec 31, 2012 | $1.17M | Feb 28, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 24 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 24 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 25 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 28 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 15 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 13 | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 18, 2020 |
| FY2019 | Sep 30, 2019 | 2 | Feb 18, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 18, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 18, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 24 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 24 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 25 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 28 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 14 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 13 | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 18, 2020 |
| FY2019 | Sep 30, 2019 | 2 | Feb 18, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 18, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 18, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | 46.74M | Feb 28, 2014 |